TelePeptide Tirzepatide Review

"Is TelePeptide legitimate?" Our assessment as of August 8, 2026.

Official Verification: TelePeptide states that clinical services are delivered by a contracted multi-state medical group of state-licensed clinicians, that every prescription is issued by a clinician licensed in the patient's state, and that medications are compounded by licensed 503A and 503B pharmacies. It publishes a state coverage list and a providers page. We found no evidence of wrongdoing.

The billing model is the strongest signal of good faith. A company that only gets paid when a clinician prescribes has an obvious incentive to prescribe. A company that charges nothing when no prescription is issued has removed the fee that would otherwise reward approving everyone — but note that it still earns nothing from a decline, so the incentive is not fully neutral either. What matters is that the patient does not lose money finding out they are not eligible, which is exactly backwards at many competitors.

The evidence disclosure sets the benchmark. Stating that the compounded product you sell was not the product studied is commercially inconvenient and factually necessary. We have criticised several companies in this comparison for doing the opposite; consistency requires crediting the one that gets it right.

The product menu is where our rating stops short of the disclosure quality. Microdosing, oral dissolvable tablets and sermorelin are all sold with careful language and no evidence. Careful language about an unevidenced product is better than reckless language, but it is not the same as evidence.

Red Flags Check:

• ✓ Nothing billed unless a clinician prescribes
• ✓ Every program and price published, no sales gates
• ✓ Refuses fabricated before-and-after imagery
• ✓ Trial figures correctly attributed, with compounded caveat stated
• ✓ Corporate structure disclosed — LLC does not practise medicine
• ✓ State exclusions published up front
• ✓ 503A/503B pharmacies; clinician licensed in your state
• ✓ Off-label uses labelled as off-label
• ⚠ Sub-therapeutic microdose tracks have no evidence base
• ⚠ Oral dissolvable tablet has no absorption or dosing data
• ⚠ Sermorelin and NAD+ sit outside evidence-based practice
• ⚠ Medical group named only on request

The Bottom Line: On conduct — pricing, billing, evidence, corporate disclosure — this is among the best-behaved operators we have reviewed, and the "billed only if prescribed" model is one we would like to see become standard. On products, stick to the standard-dose injectable semaglutide or tirzepatide programs, where the trial evidence TelePeptide cites honestly actually applies. Skip the microdose tracks, the dissolvable tablets and the peptides. As always, consult your personal physician before starting any new medication program.